Search results
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Projections Amidst Strategic Advances
GuruFocus.com via Yahoo Finance· 14 hours agoThe company, a pioneer in CRISPR/Cas9-based therapeutics, is steering groundbreaking trials in gene editing, targeting severe genetic disorders with its innovative in vivo ...
Intellia Therapeutics Q1 2024 Earnings: Aligns with Analyst Proj
Guru Focus· 14 hours agoRevenue: Reported $28.9 million in collaboration revenue for Q1 2024, surpassing the estimated $19.18 million.Net Loss: Recorded a net loss of $107.4 million,
Q1 2024 Intellia Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe have already amassed the largest set of safety and clinical activity data for any in vivo crisper based therapies. Notably, we believe our onetime treatments for ATTRNHIE ...
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery
FOX 59 Indianapolis· 9 hours agoThe Atlas™ Mouse technologies are engineered to leverage in vivo antibody selection and maturation processes for the creation of human antibodies and are specifically designed ...
Zombies from the Samsung Galaxy S24 Ultra camera: This is how bad a quickly aging close-up photo...
Weston Forum· 6 days agoThis is particularly evident in the progress Vivo is currently showing impressively in the zoom...
Mizuho analysts initates a Buy rating for Terns Pharmaceuticals Inc
Knox Daily· 5 days agoIn a filing, Terns Pharmaceuticals Inc revealed its 10% Owner Vivo Opportunity, LLC unloaded Company’s shares for reported $0.86 million on Apr 03 ’24. In the deal valued ...
Man City vs. Fulham prediction, odds, betting tips and best bets for Premier League title decider |...
Sporting News· 5 hours agoManchester City face one of their final tests of the season as they visit Craven Cottage to face...
Orchard to lose out on milestone payments as Pharming Group ends collab - Boston Business Journal
The Business Journals· 3 days agoThe companies had first announced a deal back in 2021 to work together on researching, developing,...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 16 hours agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...
Apple's foldable could have Samsung's display in it
Android Headlines· 19 hours agoUndoubtedly, Samsung is the largest foldable phone manufacturer in the world, and this is despite the intense competition from companies like Google,...
